Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission

Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission

IntroductionClinical remission (CliR) achievement has been recognized as a new potential outcome in severe asthma. Nevertheless, we still lack a detailed profile of what features could better identify patients undergoing clinical remission. In this study, we aim to address this issue, tracing a poss...

Full description

Bibliographic Details
Main Authors: Giovanna Elisiana Carpagnano, Andrea Portacci, Santi Nolasco, Aikaterini Detoraki, Alessandro Vatrella, Cecilia Calabrese, Corrado Pelaia, Francesca Montagnolo, Giulia Scioscia, Giuseppe Valenti, Maria D’Amato, Maria Filomena Caiaffa, Massimo Triggiani, Nicola Scichilone, Claudia Crimi
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
severe asthma
anti-IL5
anti-IL5 receptor
clinical remission
biologics
FEV1
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1343362/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1343362/full

Similar Items